Predictors of hepatocellular carcinoma occurrence in men with chronic hepatitis C who achieved sustained virological response with direct-acting antivirals

被引：0
|
作者：
Abu Shawish, W. [1 ,2 ]
Gan, K. M. L. [2 ]
Pradhan, S. [2 ]
Zhang, G. [3 ]
Connelly, C. [2 ]
Scagliotta, M. [2 ]
Ayonrinde, O. [2 ,4 ,5 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Fiona Stanley Hosp, Perth, Australia
[3] Sir Charles Gairdner Hosp, Perth, Australia
[4] Univ Western Australia, Perth, Australia
[5] Curtin Univ, Perth, WA, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
238
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [21] Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
    Imai, Kenji
    Takai, Koji
    Hanai, Tatsunori
    Suetsugu, Atsushi
    Shiraki, Makoto
    Shimizu, Masahito
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (02) : 111 - 116
  • [22] The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C
    Adinolfi, Luigi Elio
    Rinaldi, Luca
    Marrone, Aldo
    Giordano, Mauro
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (08) : 595 - 597
  • [23] The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
    Shereen Abou Bakr Saleh
    Khaled Mohamed Abdelwahab
    Asmaa Mady Mady
    Ghada Abdelrahman Mohamed
    Egyptian Liver Journal, 10 (1)
  • [24] The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
    Saleh, Shereen Abou Bakr
    Abdelwahab, Khaled Mohamed
    Mady, Asmaa Mady
    Mohamed, Ghada Abdelrahman
    EGYPTIAN LIVER JOURNAL, 2020, 10 (01)
  • [25] Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
    Noureddin, Mazen
    Wong, Micaela M.
    Todo, Tsuyoshi
    Lu, Shelly C.
    Sanyal, Arun J.
    Mena, Edward A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (11) : 1269 - 1277
  • [26] Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
    Mazen Noureddin
    Micaela M Wong
    Tsuyoshi Todo
    Shelly C Lu
    Arun J Sanyal
    Edward A Mena
    World Journal of Gastroenterology, 2018, 24 (11) : 1269 - 1277
  • [27] Fatty Liver Prevalence in Hepatitis C patients after Sustained Virological Response with Direct-Acting Antivirals
    Noureddin, Mazen
    Wong, Micaela
    Lu, Shelly C.
    Sanyal, Arun J.
    Mena, Edward A.
    HEPATOLOGY, 2017, 66 : 1139A - 1140A
  • [28] VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response
    Matono, Tomomitsu
    Tada, Toshifumi
    Nishimura, Takashi
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Ikeda, Naoto
    Shiomi, Hideyuki
    Enomoto, Hirayuki
    Iijima, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2024, 51 (02) : 293 - 300
  • [29] RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AND STAGE-3 LIVER FIBROSIS AFTER SUSTAINED VIROLOGICAL RESPONSE (SVR) WITH DIRECT-ACTING ANTIVIRALS (DAA)
    Sanchez-Azofra, Maria
    Fernandez, Inmaculada
    Luisa Garcia-Buey, Maria
    Dominguez, Lourdes
    Fernandez-Rodriguez, Conrado M.
    Moreno Planas, Jose Maria
    Bonet, Lucia
    Garcia Montes, Maria Luisa
    Ryan, Pablo
    Gea, Francisco
    Diaz Sanchez, Antonio
    Garcia-Mayor, Marian
    Luisa Manzano, Maria
    Gonzalez Moreno, Leticia
    Bisbal, Otilia
    Luisa Gutierrez, Maria
    Mancebo Martinez, Antonio
    Martin Carbonero, Luz
    Guerrero, Antonio
    Rivero, Miguel
    Elena Portales, Maria
    Castillo Grau, Pilar
    Olveira, Antonio
    HEPATOLOGY, 2020, 72 : 98A - 99A
  • [30] Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation
    Imamura, Taisuke
    Okamura, Yukiyasu
    Ohshima, Keiichi
    Uesaka, Katsuhiko
    Sugiura, Teiichi
    Ito, Takaaki
    Yamamoto, Yusuke
    Ashida, Ryo
    Ohgi, Katsuhisa
    Otsuka, Shimpei
    Ohnami, Sumiko
    Nagashima, Takeshi
    Hatakeyama, Keiichi
    Kakuda, Yuko
    Sugino, Takashi
    Urakami, Kenichi
    Akiyama, Yasuto
    Yamaguchi, Ken
    CANCER MEDICINE, 2022, 11 (08): : 1769 - 1786
12345